Essential hypertension
MONDO:0001134Hypertension that presents without an identifiable cause.
Also known as: idiopathic hypertension, primary hypertension
197 clinical trials for this condition and its sub-types, 182 tagged with Essential hypertension itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Essential hypertension
-
Essential hypertension, genetic 14 trials
-
Benign essential hypertension 12 trials
-
Malignant essential hypertension 0 trials
-
Can a simple lifestyle quiz lower blood pressure better than standard advice?
Disease control Not yet recruitingThis study tests whether using a 21-question tool to understand a person's daily habits, then giving tailored advice, can lower blood pressure more than routine counseling. Researchers will compare two groups of adults with hypertension over three months. The goal is to see if pe…
Sponsor: Indus Hospital and Health Network • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Alcohol injection to zap high blood pressure? new trial tests One-Time fix
Disease control Not yet recruitingThis phase 3 trial tests a procedure called renal denervation, where a small amount of alcohol is injected around the kidney nerves to calm overactive signals that raise blood pressure. 142 people with uncontrolled hypertension will either get the real procedure or a sham (fake) …
Phase 3 • Sponsor: Ablative Solutions, Inc. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Eastern diet takes on hypertension: can a 3-Month meal plan lower blood pressure?
Disease control Not yet recruitingThis trial tests whether a 3-month dietary program, called the Eastern Blood Pressure-Lowering Diet, can improve blood pressure in Chinese adults with hypertension. About 800 participants from workplace canteens will either receive standard hypertension care or also get specially…
Sponsor: Peking University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug targets immune system to fight Salt-Sensitive hypertension
Disease control Not yet recruitingThis study tests a drug called 2-HOBA in 20 adults with salt-sensitive high blood pressure. The drug aims to calm overactive immune cells that may worsen blood pressure when salt is eaten. Researchers will measure blood pressure changes and blood vessel health after taking 2-HOBA…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a breathing app and exercise team up to beat high blood pressure?
Disease control Not yet recruitingThis study looks at whether using a smartphone app to guide slow breathing, combined with aerobic exercise, can help lower blood pressure in people with essential hypertension. Seventy-five adults aged 40-50 with stage 1-2 hypertension will be split into three groups: breathing p…
Sponsor: Cairo University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Herbal capsule aims to tackle both high blood pressure and poor sleep
Disease control Not yet recruitingThis study investigates whether Songling Xuemaikang capsules, a traditional Chinese herbal formula, can help people with both high blood pressure (hypertension) and insomnia. About 260 adults aged 18–79 with mild hypertension and sleep difficulties will take either the herbal cap…
Sponsor: Jing Liu • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can common heart drugs also shield the kidneys?
Disease control Not yet recruitingThis study looks at whether two different combinations of blood pressure and cholesterol medications can help protect kidney function in people with both high blood pressure and high cholesterol. Researchers will track changes in urine protein levels and other kidney markers over…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can mindfulness lower blood pressure? new study investigates
Disease control Not yet recruitingThis study tests whether adding an 8-week online mindfulness program, called Mindfulness in Motion, to usual care helps people with high blood pressure improve their blood pressure, weight, stress, sleep, and well-being. Participants will be randomly assigned to either the mindfu…
Sponsor: Ohio State University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New blood pressure drug HCP1803-4 faces final test
Disease control Not yet recruitingThis phase 3 trial tests whether a new drug called HCP1803-4 can safely lower blood pressure in adults with essential hypertension. Participants are randomly assigned to receive either the new drug or a control drug. The study measures changes in sitting blood pressure over time …
Phase 3 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Zapping kidney nerves: a Needle-Free hope for high blood pressure?
Disease control Not yet recruitingThis pilot study tests a new device that uses radiofrequency energy to calm overactive kidney nerves, which can drive high blood pressure. Twenty adults with untreated mild hypertension will either get the real procedure or a sham (fake) one. The main goal is to see if the real t…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a chat with a nurse help control blood pressure and blood sugar?
Disease control Not yet recruitingThis pilot study in Colombia will test whether a nursing program that tailors education and counseling to each patient's needs can help people with high blood pressure or type 2 diabetes stick to their medications and achieve better disease control. About 100 to 200 adults alread…
Sponsor: Universidad Autónoma de Bucaramanga • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New blood pressure pill enters first human safety tests
Disease control Not yet recruitingThis early-stage study tests a new tablet called HS-10522 in healthy Chinese adults and those with mild hypertension. The main goal is to check safety and how the drug moves through the body. 88 participants will receive either the drug or a placebo to compare side effects and dr…
Phase 1 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Brain zaps for blood pressure: new hope for mild hypertension?
Disease control Not yet recruitingThis study tests a non-invasive device that uses gentle electrical stimulation on the brain to see if it can safely lower blood pressure in people with mild hypertension. Sixty adults aged 30-65 with mild high blood pressure will receive either real or sham stimulation for 20 min…
Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Zapping the brain to lower blood pressure? new trial launches
Disease control Not yet recruitingThis study tests a new, non-drug treatment for high blood pressure called high-intensity transcranial alternating current stimulation (Hi-tACS). It uses gentle electrical currents on the scalp to stimulate the brain. The trial will include 50 adults with primary hypertension to s…
Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Blood pressure breakthrough? device shows promise for High-Altitude hypertension
Disease control Not yet recruitingThis study tests whether a device that temporarily restricts blood flow to the arms (remote ischemic conditioning) can help lower blood pressure in people with hypertension who moved to high-altitude areas. 184 adults will either continue their usual medication or add the device …
Phase 3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New shot for high blood pressure enters first human tests
Disease control Not yet recruitingThis early-stage study tests a single injection of a new drug, IBI3016, in 30 Chinese adults with mild to moderate hypertension who are not currently on blood pressure medication. The main goal is to check safety and how the drug moves through the body, with a secondary look at i…
Phase 1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can black seed capsules tame borderline high blood pressure in women?
Disease control Not yet recruitingThis study tests whether a daily black seed extract supplement (Nisatol®) can help lower blood pressure in women with borderline high readings or a specific nighttime blood pressure pattern. 106 women will take either the supplement or a placebo for 12 weeks. Researchers will mea…
Sponsor: Liaquat University of Medical & Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a single pill replace two for high blood pressure?
Disease control Not yet recruitingThis early-stage study tests whether a new single pill containing three blood pressure medicines works the same as taking two separate pills. The trial involves 60 healthy adults who will take both versions at different times to compare how their bodies absorb the drugs. The goal…
Phase 1 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New study tests if diet and exercise can replace blood pressure pills
Disease control Not yet recruitingThis study tests a 12-week program that combines a healthy diet, exercise, sleep, and stress management with a careful plan to reduce blood pressure medication. The goal is to see if people with high blood pressure can stop taking their pills and keep their blood pressure normal.…
Sponsor: Evelyn Vanina Re • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New combo pill for high blood pressure enters first human tests
Disease control Not yet recruitingThis early-stage trial is testing a new pill called BR1015-A, which combines two common blood pressure medicines (fimasartan and indapamide) into one tablet. The study will involve 58 healthy adult volunteers to see how the body absorbs and processes the drug, and to check for an…
Phase 1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New combo pill for high blood pressure enters first human tests
Disease control Not yet recruitingThis early-stage trial tests a new combination pill (BR1015-A) containing two blood pressure medicines, Fimasartan and Indapamide, in 58 healthy adults. The goal is to see how the body absorbs and processes the drugs and to check for any safety issues. Participants will take the …
Phase 1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New combo pill for high blood pressure enters first human tests
Disease control Not yet recruitingThis early-stage trial will test a new combination pill containing two blood pressure medicines (fimasartan and indapamide) in 48 healthy adults. The study compares the combined pill to taking each drug separately, measuring how the body absorbs the drugs and checking for side ef…
Phase 1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New device zaps nerves to tame high blood pressure
Disease control Not yet recruitingThis pilot study tests a device called the Netrod renal denervation system in 20 adults with uncontrolled high blood pressure who are not taking blood pressure pills. The device uses radiofrequency energy to calm overactive kidney nerves, which may help lower blood pressure. Rese…
Sponsor: Shanghai Golden Leaf MedTec Co. Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New pill aims to tame high blood pressure in 8 weeks
Disease control Not yet recruitingThis phase 2 trial tests five different doses of an experimental drug called BR1400 in 330 adults with essential hypertension (high blood pressure). Participants take one tablet daily for 8 weeks to see how well it lowers blood pressure and if it is safe. The study compares the d…
Phase 2 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Blood pressure breakthrough? new program aims to help patients take control
Disease control Not yet recruitingThis study tests a 6-week program designed for people with high blood pressure who have low health literacy. Participants attend group sessions and get phone coaching to learn how to manage their condition. The goal is to see if this approach can lower blood pressure better than …
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New shot could control blood pressure for months
Disease control Not yet recruitingThis study tests an experimental drug called IBI3016 in people with mild to moderate high blood pressure. Participants receive either the drug or a placebo as an injection every 3 or 6 months for up to 2 years. The goal is to see if the drug safely lowers blood pressure better th…
Phase 2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New pill aims to tackle high blood pressure and weight together
Disease control Not yet recruitingThis study tests a new drug called VCT220 in 160 adults with high blood pressure who are also overweight or obese. Participants will take either VCT220 or a placebo pill for 20 weeks. The main goal is to see if VCT220 can safely lower blood pressure more than a placebo.
Phase 2 • Sponsor: Vincentage Pharma Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Fitbit data could help doctors get hypertensive patients moving
Disease control Not yet recruitingThis study will test whether giving primary care doctors easy-to-read reports from patients' Fitbits helps them counsel patients with high blood pressure to be more active. About 330 patients and their doctors will take part. The goal is to see if this simple, low-cost approach c…
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Blood pressure treatment without daily pills? new device tested
Disease control Not yet recruitingThis early study tests a device that targets specific kidney nerves to lower blood pressure. About 15 adults with high blood pressure who cannot take or tolerate standard medications will receive the procedure. The goal is to see if it is safe and can reduce blood pressure for up…
Sponsor: SyMap Medical (Suzhou), Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could a simple handgrip exercise beat walking for blood pressure?
Disease control Not yet recruitingThis study looks at whether squeezing a handgrip device or walking is better at lowering blood pressure in people with high blood pressure. About 99 adults with stage 1 hypertension will be assigned to one of the two exercises. The goal is to see which activity leads to a greater…
Sponsor: Mansoura University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Herbal capsule may slow brain vessel damage in hypertensive patients
Disease control Not yet recruitingThis study tests whether Songling Xuemaikang capsules can help control cerebral small vessel disease (CSVD), a condition where small blood vessels in the brain get damaged over time, often linked to high blood pressure. Researchers will enroll 90 adults aged 55-75 with hypertensi…
Sponsor: Dongzhimen Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New blood pressure drug takes on amlodipine in overweight patients
Disease control Not yet recruitingThis study compares a newer blood pressure drug, sacubitril/allisartan, to the standard drug amlodipine in 104 overweight or obese adults with high blood pressure. Participants will take one of the two drugs for 8 weeks, with dose adjustments if needed. The main goal is to see wh…
Phase 4 • Sponsor: Jing Liu • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a gentle brain zap help control blood pressure?
Disease control Not yet recruitingThis pilot study tests whether a non-invasive brain stimulation technique called temporal interference can safely help regulate blood pressure. Researchers will enroll 25 adults with either mild untreated hypertension or hard-to-treat hypertension, as well as people with low bloo…
Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a simple salt swap lower blood pressure in kidney transplant patients?
Disease control Not yet recruitingThis study tests whether using a potassium-enriched salt substitute (75% regular salt, 25% potassium chloride) instead of regular table salt can help control blood pressure in kidney transplant recipients. About 80 participants will use either the special salt or regular salt at …
Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jun 26, 2026 18:20 UTC
-
New blood pressure drug QLS1410 enters first human tests
Disease control Not yet recruitingThis early-stage trial will test a new drug called QLS1410 in 78 healthy adults and people with mild high blood pressure. The main goal is to check safety and how the body processes the drug. Researchers will also look at how food affects the drug and whether it lowers blood pres…
Phase 1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 12:56 UTC
-
AI-Powered 1-Minute ECG could spot hidden heart risks
Diagnosis Not yet recruitingThis study will enroll 5000 adults to see if a one-minute, single-lead ECG, analyzed by machine learning, can detect heart conditions like high blood pressure, heart failure, and diabetes. Participants will have their ECG recorded twice and compared with full medical exams. The g…
Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
Supplement mimics DASH diet to fight hypertension in african americans
Prevention Not yet recruitingThis phase 2 trial tests whether potassium magnesium citrate, a supplement that provides key nutrients from the DASH diet, can lower blood pressure in African Americans with pre- or stage 1 hypertension. The study will enroll 45 participants and measure blood pressure over 24 hou…
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
Pressing points to lower pressure: Self-Acupressure tested for hypertension
Symptom relief Not yet recruitingThis study tests whether a simple self-acupressure routine can help lower blood pressure and reduce stress in people with high blood pressure. Seventy-two adults with primary hypertension will be split into three groups: real acupressure, sham (fake) acupressure, or usual care. T…
Sponsor: Abant Izzet Baysal University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Shaking away stress: simple exercises may boost sleep in hypertension
Symptom relief Not yet recruitingThis study tests whether tension and trauma releasing exercises (TRE) can improve quality of life and sleep in 40 adults aged 50-65 with stage 1 hypertension. Participants will do supervised TRE sessions for 8 weeks. Researchers will measure changes in sleep quality and well-bein…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Weight-Loss drugs may have secret heart benefits – new study investigates
Knowledge-focused Not yet recruitingThis pilot study looks at how the diabetes and weight-loss drugs semaglutide and tirzepatide directly affect blood vessels and heart function, beyond their known effects on weight. Researchers will infuse the drugs into the arm or bloodstream of 112 volunteers with different body…
Phase 4 • Sponsor: Cambridge University Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Virtual doppelgänger may help pick right patients for kidney nerve treatment
Knowledge-focused Not yet recruitingThis pilot study will test whether a personalized computer model, called a 'digital twin,' can predict which patients with high blood pressure will respond to a procedure called renal denervation. The study will enroll 60 people, including those with resistant hypertension, untre…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Healthy volunteers needed for new blood pressure drug study
Knowledge-focused Not yet recruitingThis early-stage study tests how two experimental drugs (BR1015-1 and BR1015-2) are processed by the body when taken together or as a combined tablet. It involves 48 healthy adults who will receive single doses under fed conditions. The goal is to measure drug levels and check fo…
Phase 1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Morning workouts may tame blood pressure in glaucoma patients
Knowledge-focused Not yet recruitingThis study looks at whether different types of exercise (like walking or strength moves) and timing (morning vs. evening) can safely lower blood pressure in people with glaucoma and high blood pressure. About 60 adults will try four exercise sessions, and their blood pressure and…
Sponsor: KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Massive diabetes registry aims to unlock secrets of metabolic disease
Knowledge-focused Not yet recruitingThis 10-year observational study will follow 10,000 adults with diabetes, metabolic disorders, and related conditions like high blood pressure and fatty liver disease. Researchers will collect routine medical data to identify markers of disease severity and activity. The goal is …
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Nighttime blood pressure pattern may reveal hidden heart risks
Knowledge-focused Not yet recruitingThis study looks at whether the natural drop in blood pressure during sleep (called 'dipping') is linked to changes in the heart's electrical activity in people with high blood pressure. Researchers will monitor 140 adults using a 24-hour blood pressure device and compare those w…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC